You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection
|
|---|---|
| Published in |
Lung Cancer (01695002), January 2021
|
| DOI | 10.1016/j.lungcan.2021.01.005 |
| Pubmed ID | |
| Authors |
Mariano Provencio, Margarita Majem, María Guirado, Bartomeu Massuti, Ramón de Las Peñas, Ana Laura Ortega, Manuel Dómine, Raquel Marsé, María Ángeles Sala, Alfredo Paredes, Teresa Morán, Sergio Vázquez, Juan Coves, José Luis González Larriba, José Miguel Sánchez, David Vicente, Núria Farré, Luis Fernández Fornos, Irma Zapata, Fabio Franco, Roberto Serna-Blasco, Atocha Romero, Dolores Isla |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 4 | 50% |
| Unknown | 4 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 50% |
| Practitioners (doctors, other healthcare professionals) | 3 | 38% |
| Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 31 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 5 | 16% |
| Student > Ph. D. Student | 4 | 13% |
| Researcher | 2 | 6% |
| Unspecified | 2 | 6% |
| Lecturer | 1 | 3% |
| Other | 4 | 13% |
| Unknown | 13 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Nursing and Health Professions | 5 | 16% |
| Medicine and Dentistry | 4 | 13% |
| Biochemistry, Genetics and Molecular Biology | 3 | 10% |
| Unspecified | 1 | 3% |
| Computer Science | 1 | 3% |
| Other | 3 | 10% |
| Unknown | 14 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 May 2021.
All research outputs
#1,414,931
of 25,774,185 outputs
Outputs from Lung Cancer (01695002)
#87
of 3,059 outputs
Outputs of similar age
#38,956
of 530,990 outputs
Outputs of similar age from Lung Cancer (01695002)
#3
of 76 outputs
Altmetric has tracked 25,774,185 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,059 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 530,990 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.